↓ Skip to main content

Cochrane Database of Systematic Reviews

Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade

Overview of attention for article published in Cochrane database of systematic reviews, October 2009
Altmetric Badge

Mentioned by

wikipedia
5 Wikipedia pages

Citations

dimensions_citation
116 Dimensions

Readers on

mendeley
138 Mendeley
Title
Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade
Published in
Cochrane database of systematic reviews, October 2009
DOI 10.1002/14651858.cd007362.pub2
Pubmed ID
Authors

Amir Abrishami, Joyce Ho, Jean Wong, Ling Yin, Frances Chung

Abstract

Sugammadex is the first selective relaxant binding agent that has been studied for reversal of neuromuscular blockade induced by rocuronium and other steroidal non-depolarizing neuromuscular blocking agents (NMBAs).

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 138 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 2 1%
Japan 2 1%
Brazil 1 <1%
Australia 1 <1%
Sweden 1 <1%
United States 1 <1%
Unknown 130 94%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 15 11%
Other 14 10%
Student > Ph. D. Student 14 10%
Student > Bachelor 12 9%
Student > Master 11 8%
Other 34 25%
Unknown 38 28%
Readers by discipline Count As %
Medicine and Dentistry 67 49%
Nursing and Health Professions 8 6%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Agricultural and Biological Sciences 3 2%
Social Sciences 3 2%
Other 10 7%
Unknown 43 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 October 2022.
All research outputs
#8,571,053
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#9,070
of 11,499 outputs
Outputs of similar age
#37,844
of 106,969 outputs
Outputs of similar age from Cochrane database of systematic reviews
#53
of 81 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 106,969 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 81 others from the same source and published within six weeks on either side of this one. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.